from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0860/fadB

LFCtreatmentdescriptionclass of inhibitor

-0.943

Amikacinug/mL Amikacintranslation

-1.671

Cap5-10ug/mL Capreomycintranslation

-1.894

Rox10-50 ug/mL Roxithromycintranslation

-0.822

SM2-5 ug/mL Streptomycintranslation

-0.964

Tet5-10 ug/mL Tetracyclinetranslation

-0.956

Rif0.2-5ug/mL Rifampicintranscription

-0.672

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.000

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.557

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.023

CPZ10-50 ug/mL Chlorpromazinerespiration

0.160

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.261

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.000

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.000

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

1.139

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.301

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.000

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.192

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.921

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.046

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.000

KCN5-20 ug/mL Potassium cyaniderespiration

0.000

NaN30.2-2 mM Sodium aziderespiration

0.345

Nigericin50 uM Nigericinrespiration

0.810

TRC10-150 ug/mL Triclosanrespiration

0.000

TRZ10-25 ug/mL Thioridazinerespiration

0.237

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

0.007

menadione6-10 ug/mL Menadionerespiration

-0.286

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.391

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.471

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

1.505

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.124

NRP_1Non-replicating persistence stage 1dosRassociated

-0.528

Amp0.2mg/mL AmpicillincellWall

-0.298

Cephalexin20-100 ug/mL CephalexincellWall

-0.395

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.465

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.570

EMB10-20 ug/mL EthambutolcellWall

-0.157

Eta12-40 ug/mL EthionamidecellWall

-0.040

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.136

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.000

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.000

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

1.385

BZA0.12 mg/mL BenzamidearomaticAmides

0.923

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.496

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.152

H2O24 mM hydrogen peroxideDNAdamaging

-0.794

Levo10 ug/mL LevofloxacinDNAdamaging

0.052

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.000

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.847

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.010

UVUV-irradiationDNAdamaging

0.000

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.479

Antimycin12.5-50 ug/mL Antimycin A?

-0.102

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.485

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.597

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.461

PA8240.2-2 ug/mL PA-824?

3.903

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

1.792

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.118

Verapamil50 uM Verapamil?

0.959

mercaptoethanol2 mM 2-Mercaptoethanol?

1.927

methoxatin10-20 ug/mL Methoxatin?